Brief: BioInvent Q1 Sales SEK 22.1 Million

BioInvent International AB

29/04/2025 07:00

Apr 29 (Reuters) - BioInvent Q1 adjusted EPS SEK -1.77.

Q1 net income SEK -116.6 million

Q1 adjusted free cash flow SEK -120 million